News

Stock prices are sinking, but there's still good news for long-term investors.

Three cryptocurrencies look like good candidates to rebound this year.

The Pepeto team just hit a big milestone on its Binance level exchange, finishing the order book engine and the

The Pepeto team just announced a new security upgrade on the exchange, adding stronger AI checks on the bridge and

The Toronto-based junior miner is posting record production and revenue numbers.

Dividend strategies aren't inconsistent with growth aspirations.

Explore how each ETF’s unique sector focus and fee structure could impact your dividend strategy and long-term portfolio mix.

These ETFs are compelling as investors still struggle to capture meaningful yields from equities.

The week in crypto saw Bitcoin hold near $70,000 as Ethereum entered a "buy zone," while Nasdaq, Inc. gained SEC approval for tokenized stocks, U.S. Securities and Exchange Commission unveiled a new crypto framework, and Morgan Stanley advanced its Bitcoin ETF plans.

These ETFs can handle volatile markets.

XRP will have a hard time repeating its past success.

The key to understanding Bitcoin is the four-year cycle.

Semiconductor stocks have soared over the past couple of years. The rally doesn't look like it's over yet.

Amid escalating tensions in the Middle East, a rare scene has emerged in the cryptocurrency market: institutions bought $1.06 billion in Bitcoin ETFs in a single week, while retail investors were taking short positions. In this game of hedging versus speculation, how should ordinary investors position themselves?

We live in interesting times, and these assets are built for exactly that.

The current "buy low" opportunity and returning leadership from tech stocks make the S&P 500 a compelling buy.

Pepeto's latest presale stage sold out before its deadline after the team shipped a bridge upgrade that removes gas fees

AI stocks have had a bad 2026 so far.

This global beverage company had a strong run in 2025, and now, its stock is set to join one of the top funds in the market.

This S&P 500 ETF is low-cost and great for beginner investors.

There's good news and bad news for investors right now.

A former Binance executive inside the Ethereum based crypto Pepeto's team just moved the exchange tools into their last testing

iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but it also means giving up some upside when risk appetite shifts toward early-stage biotech companies.

The Pepeto team just completed a full security upgrade on its DeFi exchange and presale capital responded within hours. Funds